Research Article

The practice of dividing tablets: An uncertain act

Volume: 52 Number: 2 August 30, 2022
  • David Galvis Pareja *
  • Clara Ines Manrique
  • Diego Rojas Gualdron
  • Heidy Contreras
EN

The practice of dividing tablets: An uncertain act

Abstract

Background and Aims: Tablets can be split by patients for a number of reasons, using various instruments. Tablets can be scored or unscored; if scored, they may be split into pieces, and in spite of guidelines to do so patients are still at risk of re- sultant drug dose fluctuations, or being exposed to toxic or subtherapeutic doses. The aim of this study was to investigate differences in weight between halves of tablets, split by different populations and with different devices. Methods: 3-factor full factorial design (3 runs) was used with participants: patients, caregivers, nurses, medical doctors, and pharmacists; instruments: scissors, tablet cutters, knives, hand; drugs: losartan, clonidine, metoprolol, and warfarin. The risk of unequal tablet splitting was estimated and analyzed for each factor and their interaction with linearized general- ized models. Results: Differences in weight were found to be above 15% and 25% of the theoretical weight as in general, the highest weight variations after splitting were found in clonidine with patients using scissors. The overall risk of non-equal tablet splitting was 22.5% for deviations > 15% and for > 25%. Conclusion: In this study, no tablet was split into halves of equal weight; based on these findings, splitting tablets is a ques- tionable practice.

Keywords

References

  1. Arnet, I., & Hersberger, K. E. (2010). Misleading score-lines on tab- lets: Facilitated intake or fractional dosing? Swiss Medical Weekly, 140(7-8), 105-110. https://doi.org/smw-12953
  2. Cook, T. J., Edwards, S., Gyemah, C., Shah, M., Shah, I., & Fox, T. (2004). Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets. Journal of the Ameri- can Pharmacists Association: JAPhA, 44(5), 583-586. https://doi. org/10.1331/1544-3191.44.5.583.cook
  3. Elliott, I., Mayxay, M., Yeuichaixong, S., Lee, S. J., & Newton, P. N. (2014). The practice and clinical implications of tablet splitting in international health. Tropical Medicine & International Health: TM & IH, 19(7), 754-760. https://doi.org/10.1111/tmi.12309
  4. FDA. (2013). Best Practices for Tablet Splitting. https://www.fda.gov/ drugs/ensuring-safe-use-medicine/best-practices-tablet-splitting
  5. Haywood, A., & Glass, B. D. (2011). Pharmaceutical excipients – where do we begin? Australian Prescriber, 34(4), 112-114. https:// doi.org/10.18773/austprescr.2011.060
  6. Johnson, J. A. (2012). Warfarin pharmacogenetics: A rising tide for its clinical value. Circulation, 125(16), 1964-1966. https://doi. org/10.1161/CIRCULATIONAHA.112.100628
  7. Palcsó, B., & Zelkó, R. (2018). Different types, applications and lim- its of enabling excipients of pharmaceutical dosage forms. Drug Discovery Today. Technologies, 27, 21-39. https://doi.org/10.1016/j. ddtec.2018.04.002
  8. Rowley F. (s. f.). Minimize Bisect Risk: Part I. Oct 06, 2006. https:// www.pharmamanufacturing.com/articles/2006/188/

Details

Primary Language

English

Subjects

Pharmacology and Pharmaceutical Sciences

Journal Section

Research Article

Authors

David Galvis Pareja * This is me
0000-0001-8458-7547
Colombia

Clara Ines Manrique This is me
0000-0003-2605-1634
Colombia

Diego Rojas Gualdron This is me
0000-0002-2293-0431
Palestine

Heidy Contreras This is me
0000-0003-2049-4864
Colombia

Publication Date

August 30, 2022

Submission Date

June 9, 2020

Acceptance Date

December 10, 2020

Published in Issue

Year 2022 Volume: 52 Number: 2

APA
Pareja, D. G., Manrique, C. I., Gualdron, D. R., & Contreras, H. (2022). The practice of dividing tablets: An uncertain act. İstanbul Journal of Pharmacy, 52(2), 143-147. https://izlik.org/JA57TM22AE
AMA
1.Pareja DG, Manrique CI, Gualdron DR, Contreras H. The practice of dividing tablets: An uncertain act. iujp. 2022;52(2):143-147. https://izlik.org/JA57TM22AE
Chicago
Pareja, David Galvis, Clara Ines Manrique, Diego Rojas Gualdron, and Heidy Contreras. 2022. “The Practice of Dividing Tablets: An Uncertain Act”. İstanbul Journal of Pharmacy 52 (2): 143-47. https://izlik.org/JA57TM22AE.
EndNote
Pareja DG, Manrique CI, Gualdron DR, Contreras H (August 1, 2022) The practice of dividing tablets: An uncertain act. İstanbul Journal of Pharmacy 52 2 143–147.
IEEE
[1]D. G. Pareja, C. I. Manrique, D. R. Gualdron, and H. Contreras, “The practice of dividing tablets: An uncertain act”, iujp, vol. 52, no. 2, pp. 143–147, Aug. 2022, [Online]. Available: https://izlik.org/JA57TM22AE
ISNAD
Pareja, David Galvis - Manrique, Clara Ines - Gualdron, Diego Rojas - Contreras, Heidy. “The Practice of Dividing Tablets: An Uncertain Act”. İstanbul Journal of Pharmacy 52/2 (August 1, 2022): 143-147. https://izlik.org/JA57TM22AE.
JAMA
1.Pareja DG, Manrique CI, Gualdron DR, Contreras H. The practice of dividing tablets: An uncertain act. iujp. 2022;52:143–147.
MLA
Pareja, David Galvis, et al. “The Practice of Dividing Tablets: An Uncertain Act”. İstanbul Journal of Pharmacy, vol. 52, no. 2, Aug. 2022, pp. 143-7, https://izlik.org/JA57TM22AE.
Vancouver
1.David Galvis Pareja, Clara Ines Manrique, Diego Rojas Gualdron, Heidy Contreras. The practice of dividing tablets: An uncertain act. iujp [Internet]. 2022 Aug. 1;52(2):143-7. Available from: https://izlik.org/JA57TM22AE